EE304 A Cost Minimization and Budget Impact Analysis of an Eculizumab Biosimilar, ABP 959, From the Spanish Healthcare Perspective
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.1903
https://www.valueinhealthjournal.com/article/S1098-3015(25)02032-7/fulltext
Title :
EE304 A Cost Minimization and Budget Impact Analysis of an Eculizumab Biosimilar, ABP 959, From the Spanish Healthcare Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)02032-7&doi=10.1016/j.jval.2025.04.1903
First page :
Section Title :
Open access? :
No
Section Order :
10093